Helicobacter pylori therapeutics (Sankyo)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameHelicobacter pylori therapeutics (Sankyo)
Drug Alias Nameantibacterial (Sankyo)H pylori therapeutics (Sankyo)plauntolol derivatives (Sankyo)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSankyo Co Ltd
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A